Related Experiment Video
Updated: Jan 22, 2026

Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing
Published on: February 10, 2023
Single-Nucleotide Polymorphisms Sequencing Identifies Candidate Functional Variants at Prostate Cancer Risk Loci
Peng Zhang1, Lori S Tillmans2, Stephen N Thibodeau2
1Department of Pathology, MCW Cancer Center, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, USA.
This study introduces a novel sequencing technology (SNPs-seq) to identify functional genetic variants influencing prostate cancer risk. The findings reveal allele-specific protein binding at key prostate cancer loci, implicating CTBP2 and NCOA4 in disease progression.
Area of Science:
- Genetics
- Molecular Biology
- Oncology
Background:
- Genome-wide association studies have identified numerous prostate cancer risk loci, but causal variants and regulatory mechanisms remain largely uncharacterized.
- Understanding these genetic underpinnings is crucial for developing targeted therapies and improving risk prediction for prostate cancer.
Purpose of the Study:
- To develop and apply a novel sequencing technology (SNPs-seq) for identifying allele-dependent protein-DNA binding at prostate cancer risk loci.
- To characterize the functional impact of single-nucleotide polymorphisms (SNPs) associated with prostate cancer susceptibility.
- To identify candidate genes and regulatory elements involved in prostate cancer development and progression.
Main Methods:
- Utilized single-nucleotide polymorphisms sequencing (SNPs-seq) to assess allele-dependent protein binding at 903 prostate cancer risk SNPs in LNCaP cells, with and without androgen treatment.
- Performed electrophoretic mobility shift assays (EMSA) to validate allele-specific binding for selected SNPs at the CTBP2 and NCOA4 loci.
- Conducted clinical association analysis of candidate genes CTBP2 and NCOA4 in prostate cancer patient data.
Main Results:
- SNPs-seq identified significant allele-dependent protein binding in 42-45% of tested SNPs, with 74 promising candidates identified.
- EMSA validated allele-specific protein binding for rs12246440, rs7077275 (CTBP2 locus), and rs113082846 (NCOA4 locus).
- CTBP2 was upregulated and NCOA4 downregulated in prostate cancer; lower CTBP2 expression correlated with poorer recurrence-free survival.
Conclusions:
- The SNPs-seq technology is effective for identifying functional genetic variants at prostate cancer susceptibility loci.
- CTBP2 and NCOA4 are identified as candidate genes with allele-dependent regulatory mechanisms influencing prostate cancer.
- This approach provides a valuable strategy for prioritizing functional elements for further investigation in prostate cancer research.
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Histone Variants at the Centromere
Nucleotide Excision Repair
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Root Loci for Positive-Feedback Systems
The construction rules for the root locus in positive feedback systems are similar to those in...
Relative Risk

